| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Lawson MacArtney is Director at VKTX. Lawson MacArtney's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.3M at current prices.
Historically, Lawson MacArtney's trades have earned a below-average insider score of 38/100 across 4 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -63.4%.
The VKTX filings lean toward selling, a net 6,821 shares.
Lawson MacArtney has 17 Form 4 filings on record from April 2015 to January 2026, all as Director at Viking Therapeutics (VKTX), 2015–2026.
The 22 reported transactions were 12 option or other derivative awards, 4 option exercises, 4 open-market sales and 1 stock award, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $250K and 4 sales worth about $1.3M.
The only open-market purchase was 47,965 shares of VKTX at an average $5.22 on May 29, 2018, about $250K.
The largest open-market sale was 20,786 shares of VKTX at an average $20.00 on April 17, 2023, about $416K. Twelve months later VKTX was up 246%.
None of the 4 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2024 | VKTX Viking Therapeutics, Inc. | Director | Sale+OE | 2,000 | $68.67 | $137,333.40 | -4.0% | -54.1% | -46.3% | |
| May 16, 2023 | VKTX Viking Therapeutics, Inc. | Director | Sale+OE | 16,000 | $24.00 | $384,000.00 | -25.0% | -40.4% | +216.5% | |
| Apr 24, 2023 | VKTX Viking Therapeutics, Inc. | Director | Sale+OE | 16,000 | $22.00 | $352,060.80 | -25.0% | -32.0% | +204.4% | |
| Apr 17, 2023 | VKTX Viking Therapeutics, Inc. | Director | Sale+OE | 20,786 | $20.00 | $415,720.00 | -30.2% | -21.1% | +246.2% | |
| May 29, 2018 | VKTX Viking Therapeutics, Inc. | Director | Buy | 47,965 | $5.22 | $250,329.34 | New | - | - |